Skip to main content

Table 1 Demographics of the study participants

From: Utility of diffusion-weighted and contrast-enhanced magnetic resonance imaging in diagnosing and differentiating between high- and low-grade uterine endometrial stromal sarcoma

 

T2-hyperintense leiomyoma

High-grade ESS

Low-grade ESS

n

16

11

9

Age (year)

 Median (range)

43 (30–49)

64 (45–78)

42 (29–55)

Menopausal status

 Premenopausal

16 (100.0)

1 (9.1)

8 (88.9)

 Postmenopausal

0 (0.0)

10 (90.9)

1 (11.1)

FIGO staging

 I

N/A

5 (45.5)

8 (88.9)

 II

N/A

0 (0.0)

0 (0.0)

 III

N/A

4 (36.4)

1 (11.1)

 IV

N/A

2 (18.2)

0 (0.0)

Treatment

 Surgery alone

16 (100.0)

3 (27.3)

5 (55.6)

 Surgery with adjuvant treatment

N/A

7 (63.6)

4 (44.4)

 CCRT alone

N/A

1 (9.1)

0 (0.0)

  1. Data in parentheses are percentages
  2. CCRT Combined chemoradiotherapy